期刊文献+

纤溶酶和透明质酸酶诱导猪玻璃体后脱离的实验研究 被引量:3

Experimental study on plasmin and hyaluronidase inducing posterior vitrous detachment of pigs
下载PDF
导出
摘要 目的研究纤溶酶和透明质酸酶诱导猪玻璃体后脱离(PVD)的有效性和安全性,比较两种酶单独应用和联合应用的效果。方法15只小型猪随机分为A、B、C三组,每组5只,随机选取一只眼为实验眼,对侧眼为对照眼,A组实验眼玻璃体腔注射50U/0.1ml透明质酸酶,B组实验眼注射0.5U/0.1ml纤溶酶,C组实验眼注射0.5U/0.05ml纤溶酶和50U/0.05ml透明质酸酶,对照眼均注射平衡盐溶液(BSS)0.1ml。注药后进行裂隙灯、直、间接检眼镜、眼B超、视网膜电图(ERG)等检查,7d后摘除眼球进行光镜、透射电镜、扫描电镜检查。结果B超检查显示A组有一只实验眼、B组有两只实验眼于注药后1d观察到部分性PVD,C组有一只实验眼于注药后1h观察到部分性PVD。B超、光镜和扫描电镜检查显示注药后7dA组和B组实验眼均见部分性PVD,C组实验眼均见完全性PVD,对照眼未见PVD。实验及对照眼注药前、后ERGa波、b波波幅均无显著性差异,光镜及透射电镜检查未见视网膜损害。结论0.5U纤溶酶和50U透明质酸酶单独及联合应用均可快速、安全、有效地诱导猪眼玻璃体后脱离,且联合用药较单独用药诱导PVD更快速、更有效。 Objective To investigate the efficacy and safety of intravitreal injection of plasmin or hyaluronidase or the combination of these two proteases on inducing posterior vitreous detachment (PVD ) and evaluate the efficacy of these three methods. Methods 15 little type pigs were assigned to three groups ( group A, B and C ) ,5 in every group. Any eye of every pig was injected proteases ,the follow eye was control. Group A received a vitreous injection of hyaluronidase 50 U/ 0. 1ml. Group B received plasmin 0.5 U/0. 1ml. Group C received plasmin 0.5 U/0.05ml combined with hyaluronidase 50 U/0.05ml. The fellow eyes were injected 0. lml balanced salt solution(BSS). All the pigs were examined with slit -lamp biomicroscopy ,direct and indirect ophthalmoscope, B-scan and electroretinography (ERG ). After 7 days, the animals were killed and the eyes were enucleated and examined with light microscopy,transmission electron microscopy and scanning e- lectron microscopy. Results B-scan examination showed that one eye of group A and two eyes of group B had partial PVD at 1 day after injection and one eye of group C at 1 hour. B-scan,light microscopy and Scanning electron.microscopy examination demonstrated that at 7days after operation , all the eyes of group A and group B were induced partial PVD, all the control eyes no PVD. The b-wave and a-wave amplitudes of ERG showed no significant difference compared with preinjection values in all groups and between the experimental eyes and controls. Light microscopy and transmission electron microscopy inducated no damage to the retinal structure. Conclusion Intravitreal injection of hyaluronidase 50U or plasmin 0. 5U or their combination can produce PVD effectively and fast without toxicity to the histology and function of the retina. The combination of the two proteases was prior to either of them alone.
出处 《临床眼科杂志》 2007年第3期267-272,共6页 Journal of Clinical Ophthalmology
基金 武警部队医学科研课题基金资助(项目号WZ200410)
关键词 玻璃体后脱离 纤溶酶 透明质酸酶 Posterior vitreous detachment Plasmin Hyaluronidase Pig
  • 相关文献

参考文献13

  • 1Tezel TH,Del Priore LV,Kaplan HJ.Posterior vitreous detachment with dispase.Retina,1998,18:7.
  • 2Han DP,Abrams GW,Aaberg TM.Surgical excision of the attached posterior hyaloid.Arch Ophthalmol,1988,106:998.
  • 3Vander JF,Kleiner R.A method for induction of posterior vitreous detachment during vitrectomy.Retina,1992,12:172.
  • 4Trese MT.Enzymatic-assisted vitreetomy.Eye,2002,16:365.
  • 5张志红,陶海,吴海洋.酶辅助的玻璃体切割手术研究进展[J].中华眼底病杂志,2006,22(5):352-355. 被引量:5
  • 6Wang ZL,Zhang X,Xu X,et al.PVD following plasmin but not hyaluronidase:implications for combination pharmacologic vitreolysis therapy.Retina,2005,25:38.
  • 7Harooni M,McMillan T,Refojo M.Efficacy and safety of enzymatic posterior vitreous detachment by intravitreal injection of hyaluronidase.Retina,1998,18:16.
  • 8Kuppermann BD,Thomas EL,de-Smet MD,et al.Pooled efficacy Results from two multinational randomized eontrolled clinical trials of a single intravitreous injection of highly purified ovine hyaluronidasc(Vitrase)for the management of vitreous hemorrhage.Am J Ophthalmol,2005,140:573.
  • 9Kuppmmmm BD,Thomas EL,de-Smet MD,et al.Safety Results of two phase Ⅲ trials of an intravitreous injection of highly purified ovine hyaluronidase(Vitrase)for the management of vitreous hemorrhage.Am J Ophthalmol,2005,140:585.
  • 10Uemura A,Nakamura M,Kachi S,et al.Effect of plasmin on laminin and fibronectin during plasmin-assisted vitrectomy.Arch Ophthalmol,2005,123:209.

二级参考文献49

共引文献4

同被引文献39

  • 1常福厚,齐君,张晓梅,王敏杰,尹琴,扈廷茂.溶栓药替奈替普酶研究进展[J].动物医学进展,2007,28(2):67-69. 被引量:9
  • 2Bhisitkul RB. Anticipation for enzymatic vitreolysis [ J ]. Br J Ophthalmol,2001,85 ( 1 ) : 1-2.
  • 3Hermel M, Schrage NF. Efficacy of plasm in enzymes and chondroitinase ABC in creating posterior vitreous separation in the pig: aznasked, placebo-controlled in vivo study [ J ].Graefes Arch Clin Exp Ophthalmol,2007.245 (3) :399-406.
  • 4Wang F, Wang Z ,Sun X, Wang F, Xu X, Zhang X. Safety and efficacy of dispase and plasmin in pharmacologic vitreolysis [J]. Invest Ophthalmol Vis Sci,2004,24 ( 9 ) : 3286-3290.
  • 5Yamamoto T, Kamei M, Ktmavisarut P, Suzuki M, Tano Y. Increased retinal toxicity of intravitreal tissue plasminogen activator in a central retinal vein occlusion model[J]. Graefes Arch Clin Exp Ophthalmol,2008,246 ( 4 ) : 509-514.
  • 6Chen SN, Yang TC, Ho CL, Kuo YH, Yip Y, Chao AN. Retinal toxicity of intravitreal tissue plasminogen activator[J]. Ophthalmology,2003, 110 (4) :704- 708.
  • 7Davydov L, Cheng JW. Tenecteplase : a review[J]. Clin Ther, 2001,23 ( 7 ) :982-997.
  • 8Nordt TK, Bode C. Throinbolysis: newer thrombolytic agents and their role in clinical medicine [J]. Heart, 2003,89 ( 11 ) : 1358-1362.
  • 9Sinnaeve P,Mexaader J, Belmans A, Bogaerts K, Langer A, Diaz R, et al. One-year follow-up of the ASSENT-2 trial: a doubleblind, randomized comparison of single-bolus tenecteplase and front-loaded alteplase in 16949 patients with ST-elevation acute myocardial infarction [J]. Am Heart J, 2003,146 ( 1 ) :27-32.
  • 10Van de WF, Cannon CP, Luyten A, Houbracken K, McCabe C, Berioli S, et al. Safety assessment of single-bolus administration of TNK tissue-plasminogen activator in acute myocardial infarction : the ASSENT-1 trial. The ASSENT- 1 investigators [ J ]. Am Heart J, 1999,137(5 ) :786-791.

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部